Stem cell-derived exosome versus stem cell therapy
Source abstract
Abstract
Stem cell therapies are being explored for the treatment of various diseases, including haematological disease, immune disease, neurodegenerative disease, and tissue injuries. Alternatively, stem cell-derived exosomes may provide similar clinical benefits without the biosafety concerns associated with the transplantation of living cells. However, large-scale manufacturing and purification, batch-to-batch variation, and analysis of the complex cargos of exosomes will need to be addressed to enable their clinical translation.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Extracellular vesicles in disease · MicroRNA in disease regulation · RNA Interference and Gene Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (10)
Show source-provided references
1. Cao, J. et al. Developing standards to support the clinical translation of stem cells. Stem Cells Transl. Med. 10, S85–S95 (2021).10.1002/sct3.13035 ↗
2. Anisimov, S. V., Morizane, A. & Correia, A. S. Risks and mechanisms of oncological disease following stem cell transplantation. Stem Cell Rev. Rep. 6, 411–424 (2010).10.1007/s12015-010-9134-5 ↗
3. Dinh, P. C. et al. Inhalation of lung spheroid cell secretome and exosomes promotes lung repair in pulmonary fibrosis. Nat. Commun. 11, 1064 (2020).10.1038/s41467-020-14344-7 ↗
4. Kalluri, R. & LeBleu, V. S. The biology, function, and biomedical applications of exosomes. Science 367, eaau6977 (2020).10.1126/science.aau6977 ↗
5. Popowski, K. D. et al. Inhalable dry powder mRNA vaccines based on extracellular vesicles. Matter 5, 2960–2974 (2022).10.1016/j.matt.2022.06.012 ↗
6. Popowski, K. D. et al. Inhalable exosomes outperform liposomes as mRNA and protein drug carriers to the lung. Extracellular Vesicle 1, 100002 (2022).10.1016/j.vesic.2022.100002 ↗
7. Wang, Z. et al. Exosomes decorated with a recombinant SARS-CoV-2 receptor-binding domain as an inhalable COVID-19 vaccine. Nat. Biomed. Eng. 6, 791–805 (2022).10.1038/s41551-022-00902-5 ↗
8. Jang, S. C. et al. ExoSTING, an extracellular vesicle loaded with STING agonists, promotes tumor immune surveillance. Commun. Biol. 4, 497 (2021).10.1038/s42003-021-02004-5 ↗
9. Lovell-Badge, R. et al. ISSCR Guidelines for Stem Cell Research and Clinical Translation: The 2021 update. Stem Cell Reports 16, 1398–1408 (2021).10.1016/j.stemcr.2021.05.012 ↗
10. Thery, C. et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J. Extracell. Vesicles 7, 1535750 (2018).10.1080/20013078.2018.1535750 ↗